EcoDrugPlus

Xanthine Dehydrogenase

Ensembl ID : ENSCGOG00000003338
Gene Symbol: XDH
3 Cross references
211 Possible Orthologues:

Ensembl ID : ENSCGOG00000001428
Gene Symbol: -
Cross references: -
165 Possible Orthologues:

Ensembl ID : ENSCGOG00000021125
Gene Symbol: -
Cross references: -
174 Possible Orthologues:

Ensembl ID : ENSCGOG00000005515
Gene Symbol: -
Cross references: -
194 Possible Orthologues:

Ensembl ID : ENSCGOG00000012657
Gene Symbol: -
Cross references: -
163 Possible Orthologues:

Ensembl ID : ENSCGOG00000001412
Gene Symbol: -
Cross references: -
167 Possible Orthologues:

Ensembl ID : ENSCGOG00000007754
Gene Symbol: -
Cross references: -
210 Possible Orthologues:

Ensembl ID : ENSCGOG00000016786
Gene Symbol: -
Cross references: -
194 Possible Orthologues:

Ensembl ID : ENSCGOG00000000671
Gene Symbol: -
Cross references: -
126 Possible Orthologues:

Ensembl ID : ENSCGOG00000015752
Gene Symbol: -
Cross references: -
198 Possible Orthologues:

Ensembl ID : ENSCGOG00000001910
Gene Symbol: -
Cross references: -
469 Possible Orthologues:

Ensembl ID : ENSCGOG00000009995
Gene Symbol: -
Cross references: -
186 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).